NovoCure Limited (NVCR)

Last Closing Price: 17.90 (2026-05-21)

EBITDA Margin (Quarterly)

EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues

NovoCure Limited (NVCR) EBITDA Margin data is not available.

Figures for fiscal quarter ending 2026-03-31
Income Statement Financials
$174.06M
$-71.14M
$38.93M
$135.13M
$241.47M
$-67.42M
$-1.84M
$-69.26M
$-69.26M
$-71.14M
$-71.14M
$-71.14M
$-71.14M
$-67.42M
$-65.91M
114.15M
114.15M
$-0.62
$-0.62
Balance Sheet Financials
$631.66M
$99.59M
$156.26M
$787.93M
$217.58M
$234.94M
$239.63M
$457.21M
$330.72M
$330.72M
$330.72M
115.82M
Cash Flow Statement Financials
$-13.52M
$7.75M
$-0.17M
$103.39M
$97.32M
$-6.07M
$63.01M
--
--
Fundamental Metrics & Ratios
2.90
--
--
0.42
0.71
77.63%
-38.73%
-38.73%
EBITDA Margin
--
-39.79%
-40.87%
$-18.67M
--
--
--
0.22
0.90
1.19
75.70
-21.51%
-21.51%
-9.03%
-12.58%
$2.86
$-0.16
$-0.12